Philip Kranzusch, HMS professor of microbiology at Dana-Farber Cancer Institute, was one of three recipients of the 2025 Blavatnik Awards for Young Scientists. The Blavatnik Awards provide $250,000 in funding to exceptional early-career researchers, making it the nation’s largest unrestricted prize for young scientists.
The awards have become one of the most prestigious in the international scientific community, celebrating investigators who advance groundbreaking research and display exceptional talent, said Nicholas Dirks, president and CEO of the New York Academy of Sciences, which co-hosted the event.
Kranzusch was recognized for discovering that human innate immunity evolved from ancient pathways in bacteria and explaining the molecular basis for how human cells defend against infections and cancer. He found that key components of human immunity — including those targeted by vaccines and cancer immunotherapies — evolved from ancient bacterial defenses against viruses.
By reshaping fundamental understanding of immune pathways, his work opens new avenues for therapies that harness the body’s natural defenses against infections, cancer, and autoimmune disorders.
Since its inception 19 years ago, the Blavatnik Awards have recognized more than 500 honorees from 120 research institutions. They have gone on to found over 50 companies, raise 2.4 billion dollars in capital, and secure more than 7,300 patents worldwide.
Adapted from New York Academy of Sciences materials.
Karen Costenbader, HMS professor of medicine at Brigham and Women’s Hospital, received the 2025 Evelyn V. Hess Award from the Lupus Foundation of America. The Hess Award recognizes a clinical or basic researcher whose lifetime of work has significantly advanced understanding of the pathophysiology, etiology, epidemiology, diagnosis, or treatment of lupus, the chronic autoimmune disease affecting up to 1.5 million people in the United States.